News
NEW YORK, NY / ACCESS Newswire / April 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus ...
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus ...
StockStory.org on MSN5d
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals StocksDetailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...
The Felix NeuroAI wristband delivers tailored and dynamic electrical stimulation to the ulnar, median, and radial nerves ...
Strategic Combination Intended to Drive Advanced AI-Driven Drug Development and Expand Precision Medicine Applications Across ...
The Cerebral Palsy market has demonstrated substantial growth in recent years, driven by increasing awareness, improved ...
Supernus has boosted its position in central nervous system therapies with a $400 million deal to acquire Adamas Pharma that will add two approved Parkinson's disease therapies to its stable.
At close: April 11 at 4:00:01 p.m. EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback